Research Article
The Use of the Adaptation Potential Reduction Model for Reproductive Toxicity Research In Vivo
Table 2
Prenatal development of progeny F1.
| Indicators | Group | Historical control data | Control | Test | Control-19 | Control-75 | Test-19 | Test-75 |
| Number of pregnant females | 8 | 7 | 5 | 9 | — |
| Number of ovarian corpora-lutea | Total | 119 | 112 | 65 | 132 | 5–23 | M ± m | 14.88 ± 0.67 | 16.00 ± 0.82 | 13.00 ± 1.95 | 14.67 ± 0.82 | min–max | 13–19 | 13–19 | 6–18 | 10–18 |
| Number of implantation sites | Total | 100 | 101 | 53 | 101 | 3–18 | M ± m | 12.50 ± 0.73 | 14.43 ± 0.81 | 10.60 ± 2.52 | 11.22 ± 1.75 | min–max | 9–15 | 11–17 | 2–17 | 2–17 |
| Number of alive fetuses | Total | 69 | 89 | 12 | 95 | 2–18 | M ± m | 8.63 ± 1.36 | 12.71 ± 0.97 | 2.4 ± 1.69 | 10.56 ± 1.72 | min–max | 1–14 | 7–14 | 0–9 | 1–16 |
| Number of resorptions | Total | 30 | 12 | 41 | 6 | 0–10 | M ± m | 3.75 ± 1.36 | 1.71 ± 0.61 | 8.20 ± 2.85 | 0.67 ± 0.37 | min–max | 0–12 | 0–4 | 1–15 | 0–3 | Number of dead fetuses | 2 | 0 | 1 | 0 | — |
| Preimplantation loss | % | M ± m | 15.23 ± 5.39 | 9.74 ± 2.72 | 24.77 ± 11.74 | 24.11 ± 11.21 | 15 ± 1 | min–max | 0–37 | 0–22 | 0–67 | 0–83 | 0–80 |
| Absolute value | Total | 19 | 11 | 12 | 31 | 2.2 ± 0.2 | M ± m | 2.38 ± 0.91 | 1.57 ± 0.48 | 2.40 ± 0.81 | 3.44 ± 1.68 | min-max | 0–7 | 0–4 | 0–4 | 0–15 | 0–13 |
| Postimplantation loss | % | M ± m | 30.64 ± 10.41 | 12.21 ± 4.87 | 78.22 ± 17.20 | 9.37 ± 5.65 | 7 ± 1 | min–max | 0–93 | 0–36 | 10–100 | 0–50 | 0–100 |
| Absolute value | Total | 32 | 12 | 41 | 6 | 0.8 ± 0.1 | M ± m | 4.00 ± 1.46 | 1.71 ± 0.61 | 8.20 ± 2.85 | 0.67 ± 0.37 | min–max | 0–13 | 0–4 | 1–15 | 0–3 | 0–10 |
|
|
Significant differences compared to the appropriate control ( , ANOVA, Student’s t-test). |